Alector, Inc. (ALEC) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US0144421072
Alector, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 21.05 m USD |
| Operating income | -156.01 m USD |
| EBIT | -142.76 m USD |
| Net income | -142.93 m USD |
| Diluted EPS – continuing operations | -1.39 USD |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Alector, Inc.
Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer's disease; and AL050, a GCase enzyme replacement therapy in preclinical development for the potential treatment of Parkinson's disease and Lewy body dementia in patients having GBA1 gene mutations. The company also develops its preclinical and research pipeline comprising AL064, a tau siRNA for Alzheimer's disease and other tauopathies; ADP062-ABC, an alpha-synuclein siRNA for Parkinson's disease; and ADP065-ABC, an NLRP3 siRNA for neurodegenerative conditions. It has a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of progranulin-elevating monoclonal antibodies, including Latozinemab and Nivisnebart. The company was founded in 2013 and is headquartered in South San Francisco, California.
More stocks
- Anhui Fengxing Wear Resistant Materials Co Ltd (002760.SZ)
- Shandong Sino-Agri United Biotechnology Co Ltd (003042.SZ)
- Terrestrial Energy Inc. /DE/ (IMSR)
- Guangdong Redwall New Materials Co Ltd (002809.SZ)
- Western New England Bancorp, Inc. (WNEB)
- Elitegroup Computer Systems Co Ltd (2331.TW)
- Insyde Software (6231.TWO)
- Iljin HySolus Co Ltd (271940.KS)
- Zhejiang Yayi Metal Technology Co.Ltd (301113.SZ)
- CH Biotech R&D Co., Ltd. (6534.TW)
- Keyfield International Berhad (5321.KL)
- Webco Industries Inc (WEBC)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.